iShares US Pharmaceuticals ETF
IHE
IHE
122 hedge funds and large institutions have $125M invested in iShares US Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 13 closing their positions.
Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
29
Reduced
31
Closed
13
Calls
–
Puts
$233K
Net Calls
-$233K
Net Calls Change
-$233K
Top Buyers
1 |
RWP
1
RWA Wealth Partners
Newton,
Massachusetts
|
$5.53M |
2 |
2
Osaic Holdings
Scottsdale,
Arizona
|
$16M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$1.87M |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$8.28M |
5 |
5
Goldman Sachs
New York
|
$1.62M |